Switch to:
Also traded in: Brazil, Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 6/10

vs
industry
vs
history
Cash-to-Debt 0.74
NYSE:AET's Cash-to-Debt is ranked lower than
68% of the 25 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.38 vs. NYSE:AET: 0.74 )
Ranked among companies with meaningful Cash-to-Debt only.
NYSE:AET' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.32  Med: 9.73 Max: N/A
Current: 0.74
Equity-to-Asset 0.25
NYSE:AET's Equity-to-Asset is ranked lower than
68% of the 25 Companies
in the Global Health Care Plans industry.

( Industry Median: 0.34 vs. NYSE:AET: 0.25 )
Ranked among companies with meaningful Equity-to-Asset only.
NYSE:AET' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.06  Med: 0.2 Max: 0.3
Current: 0.25
0.06
0.3
Interest Coverage 4.61
NYSE:AET's Interest Coverage is ranked lower than
87% of the 23 Companies
in the Global Health Care Plans industry.

( Industry Median: 12.62 vs. NYSE:AET: 4.61 )
Ranked among companies with meaningful Interest Coverage only.
NYSE:AET' s Interest Coverage Range Over the Past 10 Years
Min: 4.61  Med: 12.26 Max: 15.48
Current: 4.61
4.61
15.48
Piotroski F-Score: 6
Altman Z-Score: 2.18
Beneish M-Score: -2.51
WACC vs ROIC
5.01%
9.82%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 8/10

vs
industry
vs
history
Operating Margin % 4.97
NYSE:AET's Operating Margin % is ranked lower than
60% of the 25 Companies
in the Global Health Care Plans industry.

( Industry Median: 5.19 vs. NYSE:AET: 4.97 )
Ranked among companies with meaningful Operating Margin % only.
NYSE:AET' s Operating Margin % Range Over the Past 10 Years
Min: 4.97  Med: 7.76 Max: 10.89
Current: 4.97
4.97
10.89
Net Margin % 1.84
NYSE:AET's Net Margin % is ranked lower than
68% of the 25 Companies
in the Global Health Care Plans industry.

( Industry Median: 3.19 vs. NYSE:AET: 1.84 )
Ranked among companies with meaningful Net Margin % only.
NYSE:AET' s Net Margin % Range Over the Past 10 Years
Min: 1.84  Med: 4.26 Max: 6.63
Current: 1.84
1.84
6.63
ROE % 6.79
NYSE:AET's ROE % is ranked lower than
83% of the 23 Companies
in the Global Health Care Plans industry.

( Industry Median: 14.42 vs. NYSE:AET: 6.79 )
Ranked among companies with meaningful ROE % only.
NYSE:AET' s ROE % Range Over the Past 10 Years
Min: 6.79  Med: 15.65 Max: 19.85
Current: 6.79
6.79
19.85
ROA % 1.78
NYSE:AET's ROA % is ranked lower than
80% of the 25 Companies
in the Global Health Care Plans industry.

( Industry Median: 4.26 vs. NYSE:AET: 1.78 )
Ranked among companies with meaningful ROA % only.
NYSE:AET' s ROA % Range Over the Past 10 Years
Min: 1.78  Med: 4.05 Max: 5.2
Current: 1.78
1.78
5.2
ROC (Joel Greenblatt) % 461.02
NYSE:AET's ROC (Joel Greenblatt) % is ranked higher than
86% of the 21 Companies
in the Global Health Care Plans industry.

( Industry Median: 89.82 vs. NYSE:AET: 461.02 )
Ranked among companies with meaningful ROC (Joel Greenblatt) % only.
NYSE:AET' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: 421.13  Med: 565.4 Max: 919.39
Current: 461.02
421.13
919.39
3-Year Revenue Growth Rate 10.60
NYSE:AET's 3-Year Revenue Growth Rate is ranked higher than
57% of the 21 Companies
in the Global Health Care Plans industry.

( Industry Median: 10.60 vs. NYSE:AET: 10.60 )
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
NYSE:AET' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: -15.7  Med: 5.3 Max: 22
Current: 10.6
-15.7
22
3-Year EBITDA Growth Rate 11.60
NYSE:AET's 3-Year EBITDA Growth Rate is ranked lower than
53% of the 19 Companies
in the Global Health Care Plans industry.

( Industry Median: 11.80 vs. NYSE:AET: 11.60 )
Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.
NYSE:AET' s 3-Year EBITDA Growth Rate Range Over the Past 10 Years
Min: 0  Med: 2.6 Max: 76.7
Current: 11.6
0
76.7
3-Year EPS without NRI Growth Rate 6.30
NYSE:AET's 3-Year EPS without NRI Growth Rate is ranked lower than
53% of the 17 Companies
in the Global Health Care Plans industry.

( Industry Median: 9.40 vs. NYSE:AET: 6.30 )
Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.
NYSE:AET' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -13  Med: 6.4 Max: 63.9
Current: 6.3
-13
63.9
GuruFocus has detected 7 Warning Signs with Aetna Inc $NYSE:AET.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» NYSE:AET's 30-Y Financials

Financials (Next Earnings Date: 2017-08-02 Est.)


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Health Care Plans » Health Care Plans    NAICS: 524114    SIC: 6324
Compare:NYSE:ANTX, NYSE:CI, NAS:ESRX, NYSE:HUM, NYSE:CVS, NYSE:CNC, NYSE:WCG, NYSE:MOH, NAS:MGLN, NYSE:UAM, NAS:HIIQ, OTCPK:OPRX, OTCPK:WCUI, NAS:CNXR, NYSE:UNH » details
Traded in other countries:AETB34.Brazil, HE8.Germany,
Headquarter Location:USA
Aetna Inc is a health care benefit company. The Company offers traditional and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans.

Aetna is one of the largest managed-care organizations in the U.S., with over 22 million medical members. This member count will increase significantly if the firm is able to close the Humana acquisition. The firm provides health insurance services to its members through products that encompass every major insurance market--individual, group, and government sponsored. Aetna has a large nationwide operation and competes in most major U.S. geographies.

Top Ranked Articles about Aetna Inc

David Swensen Sells 5 Holdings, Buys 2 Others An overview of the guru's 1st-quarter trades
David Swensen (Trades, Portfolio) is responsible for managing Yale University's endowment assets and investment funds. He manages a portfolio of six stocks worth $495 million. During the first quarter, the guru traded shares in the following stocks: Read more...
Edward Owens Buys Abbott Labs, Sells Allergan, Amgen, Aetna Vanguard Health Care Fund's largest 1st-quarter trades
Edward Owens has managed the Vanguard Health Care Fund (Trades, Portfolio) since its inception in May 1984. It invests primarily in health care companies. Read more...
Insiders Roundup: Facebook, General Electric, Aetna The largest insider trades of the week
The GuruFocus All-in-One Screener can be used to find insider trades from the past week. Under the Insiders tab, change the settings for All Insider Buying to “$200,000+,” the duration to “March 2017” and All Insider Sales to “$5,000,000+.” Read more...
Eaton Vance Worldwide Health Sciences Fund Adds 4 Stocks to Portfolio Health care fund reports fourth-quarter activity
Jason Kritzer, vice president of Eaton Vance Management, invests in companies with a bottom-up, proprietary research approach. The portfolio manager of the Eaton Vance Worldwide Health Sciences Fund (Trades, Portfolio) invested in four companies during the first quarter: Aetna Inc. (NYSE:AET), Humana Inc. (NYSE:HUM), Hologic Inc. (NASDAQ:HOLX) and Teleflex Inc. (NYSE:TFX) Read more...
Diamond Hill Sells Morgan Stanley and IBM, Buys Pepsi The guru's largest 4th-quarter trades
Diamond Hill Capital (Trades, Portfolio) is a registered investment adviser based in Columbus, Ohio. During the fourth quarter the guru traded shares in the following stocks: Read more...
DEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Aetna Inc. (AET) & Lead Plaintiff Deadline - March 27, 2017

NEW YORK, March 24, 2017 (GLOBE NEWSWIRE) -- -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against Aetna Inc. (“Aetna” or the “Company”) (:AET) and certain of its officers, on behalf of shareholders who purchased Aetna securities between August 15, 2016 and January 20, 2017, inclusive (the “Class Period”). Such investors are encouraged to join this case by visiting the firm’s site: http://www.bgandg.com/aet. This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934. The complaint alleges that throughout the Class Period Defendants made false and/or misleading statements and/or failed to disclose that: (1) Aetna and its senior executives tried to influence Aetna’s participation in the Public Exchanges for positive treatment from regulators regarding the Humana acquisition; (2) Aetna threatened to limit its involvement in public health insurance exchanges if the Department of Justice (“DOJ”) tried to block the merger; (3) Aetna did not withdraw from certain public health insurance exchanges for business reasons as Defendants claimed, but to follow through on its threat of leaving the marketplace once the DOJ filed suit and to improve its litigation position; (4) Aetna withdrew from public health insurance exchanges that were profitable for Aetna; and (5) consequently, Defendants’ statements regarding Aetna’s business, operations, and prospects were false and misleading and/or lacked a reasonable basis. A class action lawsuit has already been filed. If you wish to review a copy of the Complaint you can visit the firm’s site: http://www.bgandg.com/aet or you may contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484. If you suffered a loss in Aetna you have until March 27, 2017 to request that the Court appoint you as lead plaintiff.  Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique.  Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients.  In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm’s expertise includes general corporate and commercial litigation, as well as securities arbitration.   Attorney advertising. Prior results do not guarantee similar outcomes.
Contact:
Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz
212-697-6484 | [email protected]

Read more...
INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Aetna Inc. and Encourages Investors with Losses to Contact the Firm

LOS ANGELES, March 24, 2017 (GLOBE NEWSWIRE) -- Lundin Law PC, a shareholder rights firm announces a class action lawsuit against Aetna Inc. (“Aetna” or the “Company”) (:AET) concerning possible violations of federal securities laws. Investors who purchased or otherwise acquired shares between August 15, 2016 and January 20, 2017 inclusive (the “Class Period”), are encouraged to contact the firm in advance of the March 27, 2017 lead plaintiff motion deadline.
To participate in this class action lawsuit, click here, or call Brian Lundin, Esquire, of Lundin Law PC, at 888-713-1033, or e-mail him at [email protected]. No class has been certified in the above action yet. Until certification occurs, you are not represented by an attorney. You may choose to take no action and remain a passive class member. The Complaint alleges that during the Class Period, Defendants made false and/or misleading statements and/or failed to disclose that: Aetna and its senior executives tried to influence Aetna's participation in the Public Exchanges for positive treatment from regulators regarding the Humana acquisition; that the Company threatened to cut back its participation in public health insurance exchanges if the Department of Justice ("DOJ") tried to block the merger; that Aetna withdraw from some public health insurance exchanges to complete its threat of leaving the marketplace once the DOJ filed suit to better its litigation; that Aetna withdrew from public health insurance exchanges that were profitable for Aetna; and that due to the above, Defendants' statements regarding Aetna's business, operations, and prospects were false and misleading and/or lacked a reasonable basis. When this information was released to the public, the value of Aetna stock fell, causing investors harm. Lundin Law PC was established by Brian Lundin, a securities litigator based in Los Angeles dedicated to upholding shareholders' rights. This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
Contact:

Lundin Law PC
Brian Lundin, Esq.
Telephone: 888-713-1033
Facsimile: 888-713-1125
[email protected]

Read more...
Pioneer Investments Exits Wells Fargo, Coca-Cola, Buys Walt Disney The guru's largest 4th-quarter transactions
Pioneer Investment Management operates in wide areas of investment vehicles: mutual funds, single manager hedge funds, funds of hedge funds, structured products, segregated and managed accounts and institutional funds. During the fourth quarter of 2016, the firm traded shares in the following stocks: Read more...
AET INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of Commencement of a Class Action Involving Aetna Inc. and a Lead Plaintiff Deadline of March 27, 2017

NEW YORK, March 21, 2017 (GLOBE NEWSWIRE) -- The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the District of Connecticut on behalf of investors who purchased Aetna Inc. (:AET) securities between August 15, 2016 through January 20, 2017.
Click here to learn about the case: http://www.wongesq.com/pslra/aetna-inc. There is no cost or obligation to you. According to the complaint, throughout the class period Aetna made false and/or misleading statements and/or failed to disclose that: (1) Aetna and its senior executives attempted to leverage Aetna’s participation in the Public Exchanges for favorable treatment from regulators regarding the Humana acquisition; (2) Aetna threatened to limit its participation in public health insurance exchanges if the Department of Justice (“DOJ”) attempted to block the merger; (3) Aetna did not withdraw from certain public health insurance exchanges for business reasons as Defendants claimed, but to follow through on its threat of leaving the marketplace once the DOJ filed suit and to improve its litigation position; (4) Aetna withdrew from public health insurance exchanges that were profitable for Aetna; and (5) as a result of the foregoing, Defendants’ statements about Aetna’s business, operations, and prospects were false and misleading and/or lacked a reasonable basis. If you suffered a loss in Aetna you have until March 27, 2017 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff. To obtain additional information, contact Vincent Wong, Esq. either via email [email protected], by telephone at 212.425.1140, or visit http://www.wongesq.com/pslra/aetna-inc. Vincent Wong, Esq. is an experienced attorney that has represented investors in securities litigations involving financial fraud and violations of shareholder rights.  Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
Vincent Wong, Esq.
39 East Broadway
Suite 304
New York, NY 10002
Tel. 212.425.1140
Fax. 866.699.3880
E-Mail: [email protected]

Read more...
INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Investors of Aetna Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of March 27, 2017 – AET

NEW YORK, March 17, 2017 (GLOBE NEWSWIRE) -- The following statement is being issued by Levi & Korsinsky, LLP:
To: All persons or entities who purchased or otherwise acquired securities of Aetna Inc. (:AET) between August 15, 2016 through January 20, 2017. You are hereby notified that a securities class action lawsuit has been commenced in the USDC for the District of Connecticut. To get more information go to: http://www.zlk.com/pslra/aetna-inc or contact Joseph E. Levi, Esq. either via email at [email protected] or by telephone at (212) 363-7500, toll-free: (877) 363-5972. There is no cost or obligation to you. The complaint alleges that throughout the class period Aetna made false and/or misleading statements and/or failed to disclose that: (1) Aetna and its senior executives attempted to leverage Aetna’s participation in the Public Exchanges for favorable treatment from regulators regarding the Humana acquisition; (2) Aetna threatened to limit its participation in public health insurance exchanges if the Department of Justice (“DOJ”) attempted to block the merger; (3) Aetna did not withdraw from certain public health insurance exchanges for business reasons as Defendants claimed, but to follow through on its threat of leaving the marketplace once the DOJ filed suit and to improve its litigation position; (4) Aetna withdrew from public health insurance exchanges that were profitable for Aetna; and (5) as a result of the foregoing, Defendants’ statements about Aetna’s business, operations, and prospects were false and misleading and/or lacked a reasonable basis. If you suffered a loss in Aetna you have until March 27, 2017 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff. Levi & Korsinsky is a national firm with offices in New York, California, Connecticut, and Washington D.C. The firm’s attorneys have extensive expertise and experience representing investors in securities litigation, and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
30 Broad Street - 24th Floor
New York, NY 10004
Tel: (212) 363-7500
Toll Free: (877) 363-5972
Fax: (212) 363-7171
www.zlk.com


Read more...

Ratios

vs
industry
vs
history
PE Ratio 47.10
AET's PE Ratio is ranked lower than
100% of the 22 Companies
in the Global Health Care Plans industry.

( Industry Median: 21.18 vs. AET: 47.10 )
Ranked among companies with meaningful PE Ratio only.
AET' s PE Ratio Range Over the Past 10 Years
Min: 5.42  Med: 12.61 Max: 47.38
Current: 47.1
5.42
47.38
Forward PE Ratio 17.09
AET's Forward PE Ratio is ranked higher than
64% of the 11 Companies
in the Global Health Care Plans industry.

( Industry Median: 17.39 vs. AET: 17.09 )
Ranked among companies with meaningful Forward PE Ratio only.
N/A
PE Ratio without NRI 47.10
AET's PE Ratio without NRI is ranked lower than
100% of the 21 Companies
in the Global Health Care Plans industry.

( Industry Median: 21.18 vs. AET: 47.10 )
Ranked among companies with meaningful PE Ratio without NRI only.
AET' s PE Ratio without NRI Range Over the Past 10 Years
Min: 5.42  Med: 12.61 Max: 47.38
Current: 47.1
5.42
47.38
Price-to-Owner-Earnings 26.82
AET's Price-to-Owner-Earnings is ranked lower than
88% of the 17 Companies
in the Global Health Care Plans industry.

( Industry Median: 9.73 vs. AET: 26.82 )
Ranked among companies with meaningful Price-to-Owner-Earnings only.
AET' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 5.35  Med: 12.42 Max: 26.98
Current: 26.82
5.35
26.98
PB Ratio 3.52
AET's PB Ratio is ranked lower than
61% of the 23 Companies
in the Global Health Care Plans industry.

( Industry Median: 2.78 vs. AET: 3.52 )
Ranked among companies with meaningful PB Ratio only.
AET' s PB Ratio Range Over the Past 10 Years
Min: 0.88  Med: 1.82 Max: 3.54
Current: 3.52
0.88
3.54
PS Ratio 0.85
AET's PS Ratio is ranked lower than
58% of the 24 Companies
in the Global Health Care Plans industry.

( Industry Median: 0.64 vs. AET: 0.85 )
Ranked among companies with meaningful PS Ratio only.
AET' s PS Ratio Range Over the Past 10 Years
Min: 0.29  Med: 0.54 Max: 1.13
Current: 0.85
0.29
1.13
Price-to-Free-Cash-Flow 20.86
AET's Price-to-Free-Cash-Flow is ranked lower than
76% of the 17 Companies
in the Global Health Care Plans industry.

( Industry Median: 10.35 vs. AET: 20.86 )
Ranked among companies with meaningful Price-to-Free-Cash-Flow only.
AET' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 4.49  Med: 11.42 Max: 23.57
Current: 20.86
4.49
23.57
Price-to-Operating-Cash-Flow 18.75
AET's Price-to-Operating-Cash-Flow is ranked lower than
70% of the 20 Companies
in the Global Health Care Plans industry.

( Industry Median: 11.27 vs. AET: 18.75 )
Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.
AET' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 3.68  Med: 9.63 Max: 18.87
Current: 18.75
3.68
18.87
EV-to-EBIT 19.16
AET's EV-to-EBIT is ranked lower than
90% of the 20 Companies
in the Global Health Care Plans industry.

( Industry Median: 13.25 vs. AET: 19.16 )
Ranked among companies with meaningful EV-to-EBIT only.
AET' s EV-to-EBIT Range Over the Past 10 Years
Min: 3.1  Med: 7.3 Max: 19.9
Current: 19.16
3.1
19.9
EV-to-EBITDA 15.40
AET's EV-to-EBITDA is ranked lower than
71% of the 21 Companies
in the Global Health Care Plans industry.

( Industry Median: 10.19 vs. AET: 15.40 )
Ranked among companies with meaningful EV-to-EBITDA only.
AET' s EV-to-EBITDA Range Over the Past 10 Years
Min: 2.8  Med: 6.4 Max: 16
Current: 15.4
2.8
16
PEG Ratio 4.40
AET's PEG Ratio is ranked lower than
79% of the 14 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.82 vs. AET: 4.40 )
Ranked among companies with meaningful PEG Ratio only.
AET' s PEG Ratio Range Over the Past 10 Years
Min: 0.25  Med: 0.94 Max: 6.51
Current: 4.4
0.25
6.51
Shiller PE Ratio 30.85
AET's Shiller PE Ratio is ranked lower than
69% of the 13 Companies
in the Global Health Care Plans industry.

( Industry Median: 27.81 vs. AET: 30.85 )
Ranked among companies with meaningful Shiller PE Ratio only.
AET' s Shiller PE Ratio Range Over the Past 10 Years
Min: 10.39  Med: 19 Max: 44.8
Current: 30.85
10.39
44.8
Current Ratio 0.77
AET's Current Ratio is ranked lower than
71% of the 21 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.19 vs. AET: 0.77 )
Ranked among companies with meaningful Current Ratio only.
AET' s Current Ratio Range Over the Past 10 Years
Min: 0.54  Med: 0.88 Max: 2.78
Current: 0.77
0.54
2.78
Quick Ratio 0.77
AET's Quick Ratio is ranked lower than
67% of the 21 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.19 vs. AET: 0.77 )
Ranked among companies with meaningful Quick Ratio only.
AET' s Quick Ratio Range Over the Past 10 Years
Min: 0.54  Med: 0.88 Max: 2.78
Current: 0.77
0.54
2.78
Days Sales Outstanding 31.57
AET's Days Sales Outstanding is ranked lower than
60% of the 20 Companies
in the Global Health Care Plans industry.

( Industry Median: 25.28 vs. AET: 31.57 )
Ranked among companies with meaningful Days Sales Outstanding only.
AET' s Days Sales Outstanding Range Over the Past 10 Years
Min: 16.34  Med: 26.33 Max: 31.57
Current: 31.57
16.34
31.57
Days Payable 50.55
AET's Days Payable is ranked higher than
69% of the 13 Companies
in the Global Health Care Plans industry.

( Industry Median: 44.46 vs. AET: 50.55 )
Ranked among companies with meaningful Days Payable only.
AET' s Days Payable Range Over the Past 10 Years
Min: 38.83  Med: 47.09 Max: 52.51
Current: 50.55
38.83
52.51

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield % 0.83
AET's Dividend Yield % is ranked lower than
84% of the 31 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.38 vs. AET: 0.83 )
Ranked among companies with meaningful Dividend Yield % only.
AET' s Dividend Yield % Range Over the Past 10 Years
Min: 0.05  Med: 0.78 Max: 1.77
Current: 0.83
0.05
1.77
Dividend Payout Ratio 0.31
AET's Dividend Payout Ratio is ranked higher than
75% of the 12 Companies
in the Global Health Care Plans industry.

( Industry Median: 0.25 vs. AET: 0.31 )
Ranked among companies with meaningful Dividend Payout Ratio only.
AET' s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.01  Med: 0.12 Max: 0.31
Current: 0.31
0.01
0.31
3-Year Dividend Growth Rate 7.70
AET's 3-Year Dividend Growth Rate is ranked higher than
50% of the 8 Companies
in the Global Health Care Plans industry.

( Industry Median: 7.70 vs. AET: 7.70 )
Ranked among companies with meaningful 3-Year Dividend Growth Rate only.
AET' s 3-Year Dividend Growth Rate Range Over the Past 10 Years
Min: 0  Med: 0 Max: 171.4
Current: 7.7
0
171.4
Forward Dividend Yield % 1.32
AET's Forward Dividend Yield % is ranked lower than
81% of the 27 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.65 vs. AET: 1.32 )
Ranked among companies with meaningful Forward Dividend Yield % only.
N/A
5-Year Yield-on-Cost % 1.74
AET's 5-Year Yield-on-Cost % is ranked lower than
71% of the 41 Companies
in the Global Health Care Plans industry.

( Industry Median: 5.04 vs. AET: 1.74 )
Ranked among companies with meaningful 5-Year Yield-on-Cost % only.
AET' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0.11  Med: 1.64 Max: 3.72
Current: 1.74
0.11
3.72
3-Year Average Share Buyback Ratio 1.00
AET's 3-Year Average Share Buyback Ratio is ranked higher than
56% of the 18 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.00 vs. AET: 1.00 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
AET' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -10.2  Med: 0.6 Max: 8.8
Current: 1
-10.2
8.8

Valuation & Return

vs
industry
vs
history
Price-to-Tangible-Book 22.37
AET's Price-to-Tangible-Book is ranked lower than
81% of the 16 Companies
in the Global Health Care Plans industry.

( Industry Median: 6.27 vs. AET: 22.37 )
Ranked among companies with meaningful Price-to-Tangible-Book only.
AET' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 0.55  Med: 3.62 Max: 23.42
Current: 22.37
0.55
23.42
Price-to-Intrinsic-Value-Projected-FCF 1.13
AET's Price-to-Intrinsic-Value-Projected-FCF is ranked lower than
53% of the 17 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.04 vs. AET: 1.13 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-Projected-FCF only.
AET' s Price-to-Intrinsic-Value-Projected-FCF Range Over the Past 10 Years
Min: 0.23  Med: 0.68 Max: 2
Current: 1.13
0.23
2
Price-to-Intrinsic-Value-DCF (Earnings Based) 3.28
AET's Price-to-Intrinsic-Value-DCF (Earnings Based) is ranked lower than
90% of the 10 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.60 vs. AET: 3.28 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-DCF (Earnings Based) only.
N/A
Price-to-Median-PS-Value 1.58
AET's Price-to-Median-PS-Value is ranked lower than
68% of the 22 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.23 vs. AET: 1.58 )
Ranked among companies with meaningful Price-to-Median-PS-Value only.
AET' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.29  Med: 0.84 Max: 2.35
Current: 1.58
0.29
2.35
Price-to-Peter-Lynch-Fair-Value 4.98
AET's Price-to-Peter-Lynch-Fair-Value is ranked lower than
100% of the 12 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.63 vs. AET: 4.98 )
Ranked among companies with meaningful Price-to-Peter-Lynch-Fair-Value only.
AET' s Price-to-Peter-Lynch-Fair-Value Range Over the Past 10 Years
Min: 0.19  Med: 0.83 Max: 5.14
Current: 4.98
0.19
5.14
Price-to-Graham-Number 6.84
AET's Price-to-Graham-Number is ranked lower than
92% of the 12 Companies
in the Global Health Care Plans industry.

( Industry Median: 2.77 vs. AET: 6.84 )
Ranked among companies with meaningful Price-to-Graham-Number only.
AET' s Price-to-Graham-Number Range Over the Past 10 Years
Min: 0.36  Med: 1.52 Max: 6.84
Current: 6.84
0.36
6.84
Earnings Yield (Greenblatt) % 5.22
AET's Earnings Yield (Greenblatt) % is ranked lower than
72% of the 25 Companies
in the Global Health Care Plans industry.

( Industry Median: 6.65 vs. AET: 5.22 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
AET' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: 5  Med: 13.75 Max: 32.2
Current: 5.22
5
32.2
Forward Rate of Return (Yacktman) % 14.46
AET's Forward Rate of Return (Yacktman) % is ranked lower than
67% of the 15 Companies
in the Global Health Care Plans industry.

( Industry Median: 16.88 vs. AET: 14.46 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) % only.
AET' s Forward Rate of Return (Yacktman) % Range Over the Past 10 Years
Min: 6  Med: 19.8 Max: 54.9
Current: 14.46
6
54.9

More Statistics

Revenue (TTM) (Mil) $62,626.60
EPS (TTM) $ 3.21
Beta0.60
Short Percentage of Float3.03%
52-Week Range $104.59 - 155.15
Shares Outstanding (Mil)331.70

Analyst Estimate

Dec17 Dec18 Dec19
Revenue (Mil $) 60,569 62,515 66,028
EPS ($) 8.79 9.91 11.08
EPS without NRI ($) 8.79 9.91 11.08
EPS Growth Rate
(Future 3Y To 5Y Estimate)
14.64%
Dividends per Share ($) 1.34 1.34 1.50
» More Articles for AET

Headlines

Articles On GuruFocus.com
Credit Suisse Income Fund Announces Monthly Dividend Jun 27 2017 
GAMCO Analyst: Is VMware a Compelling Investment Idea in Data Infrastructure? Jun 26 2017 
Gabelli TV: 2017 American Water Works Annual Conference Recap Jun 26 2017 
Monthly Dividend Stocks to Pay Your Bills Jun 26 2017 
The Rubicon Project: Who Is Selling and Why It's Creating a Bargain Price Jun 26 2017 
Sports, Stocks and the Magic Quadrants Jun 26 2017 
Israel Englander More Than Doubles Stake in Carter's Jun 27 2017 
GMO Global Equity Insights - Whiplash: On Value, Growth and Ignoring the Fundamentals Jun 26 2017 
Dan Loeb's Third Point Letter on $3.5 Billion Nestle Purchase, Plans to Sells L'Oreal Jun 26 2017 
Canaries in the Coal Mine – What to Watch as Stocks Continue to Make New Highs Jun 26 2017 

More From Other Websites
Medtronic Announces Outcomes-Based Agreement with Aetna for Type 1 and Type 2 Diabetes Patients Jun 26 2017
Aetna Inks New Deal to Improve Healthcare in North Carolina Jun 26 2017
Medtronic deal with Aetna ties insulin pump payment to patient results Jun 26 2017
Here's What to Watch as the Senate Fights Over Healthcare Reform Jun 24 2017
3 Best Healthcare Dividend Stocks of the 21st Century (So Far) Jun 24 2017
The Largest Company in Every State Jun 23 2017
Health care on pace from best week of the year Jun 23 2017
White House Confident Healthcare Bill Passes Before August Recess Jun 23 2017
Yahoo Finance Live: Market Movers - Jun 23rd, 2017 Jun 23 2017
Senate Republicans unveil Obamacare replacement bill, but fate uncertain Jun 22 2017
Senate Republicans unveil Obamacare replacement bill, fate uncertain Jun 22 2017
Mark Bertolini: We’re moving Aetna, but not telling anybody where yet Jun 21 2017
Government health insurance markets holding up--barely Jun 21 2017
Mark Bertolini: We’re Moving Aetna, but not telling anybo... Jun 21 2017
Anthem Blue Cross Exits Obamacare In Two More Red States Jun 21 2017
Aetna and Community Care Physician Network Sign Collaborative Agreement Jun 21 2017
S&P 500 Buybacks Fall 17.5% Year-over-Year to $133.1 Billion for Q1 2017 Jun 21 2017
Is Aetna (AET) a Great Stock for Value Investors? Jun 19 2017
​Sutter Health, Aetna announce new Northern California health plan Jun 13 2017
Key insurer Centene plans to expand health exchange presence Jun 13 2017

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}